Yoann Athiel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yoann Athiel has a total of 121 co-authors. Here are the top co-authors by number of shared publications:
François Goffinet
Department of Obstetrics and Gynecology, Port‐Royal Maternity Université Paris Cité, APHP Paris France
9 shared publicationsAude Girault
Department of Obstetrics and Gynecology, Port‐Royal Maternity Université Paris Cité, APHP Paris France
6 shared publicationsVassilis Tsatsaris
Maternité Port-Royal, Groupe Hospitalier Cochin Broca Hôtel-Dieu, Assistance Publique-Hôpitaux de Paris, Paris, France
6 shared publications- Jean-Marie Jouannic
Fetal Medicine Department Armand Trousseau Hospital Sorbonne University AP‐HP Paris France
4 shared publications Camille Le Ray
Port Royal Maternity Department, Hôpital Cochin Port-Royal, APHP, Université Paris Cité, Paris, France; Obstetrical, Perinatal, Pediatric Life Course Epidemiology Research Team (OPPaLE), Centre for Research in Epidemiology and Statistics (CRESS), Inserm, Université Paris Cité, France
3 shared publicationsGilles Kayem
3 shared publications
Latest Publications
- Open Access
- 20 September 2026
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 68 (4) , 518-526
Prenatal findings and postnatal outcomes in cases of closed spinal dysraphism: 10‐year two‐center cohort study
Objective: To characterize prenatal ultrasound findings in fetuses with prenatally diagnosed closed spinal dysraphism (CSD) and report their postnatal management and functional outcomes at 18 and 36 months. Methods: This retrospective cohort study included all fetuses with a prenatal diagnosis of CSD assessed between January 2014 and December 2024 at two tertiary centers (Fetal Medicine Department of Trousseau Hospital, Paris, France, and Department of Obstetrics and Gynecology, University Hospitals Leuven, Leuven, Belgium). Lesions were reassessed and classified according to the updated Orphanet classification system for dysraphisms. Cases of open dysraphism, intermediate forms, Currarino syndrome, caudal regression syndrome and postnatally diagnosed cases were excluded. Prenatal imaging findings, pregnancy outcomes, postnatal diagnostic concordance, neurosurgical management and functional outcomes were analyzed. Results: Seventy fetuses with a prenatal diagnosis of CSD were included. Saccular forms of CSD accounted for 85.7% ( n = 60) of cases, including 33 (47.1%) cases of limited dorsal myeloschisis, 18 (25.7%) cases of posterior meningocele and nine (12.9%) cases of conus spinal cord lipoma. Most (85.7%) lesions were located at the lumbar or sacral level. Associated structural cerebral anomalies were identified prenatally in 17.1% ( n = 12) of cases. There were 59 (84.3%) live births and 11 (15.7%) terminations of pregnancy, including eight cases with major cerebral anomalies. Among liveborn infants with available data on postnatal surgical interventions ( n/N = 44/59), postnatal surgery was performed in 90.9% of cases. The prenatal diagnosis was adjusted postnatally in 4/39 (10.3%) cases with available postnatal outcome data. At 36 months, independent ambulation was achieved in 94.4% (17/18) of children with follow‐up data available at this time point. In contrast, urinary dysfunction was present in 38.9% of cases at 36 months, while gastrointestinal disorders were less frequent (22.2%). Conclusion: Using the Orphanet classification, prenatal ultrasound examination allows reliable anatomical characterization of CSD in 89.7% of cases. Motor outcomes are generally favorable, whereas urological morbidity is observed in nearly half of cases at 18 months. These are important elements to consider in prenatal counseling. © 2026 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
- 20 September 2026
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 68 (4) , 518-526
Open AccessPrenatal findings and postnatal outcomes in cases of closed spinal dysraphism: 10‐year two‐center cohort study
Objective: To characterize prenatal ultrasound findings in fetuses with prenatally diagnosed closed spinal dysraphism (CSD) and report their postnatal management and functional outcomes at 18 and 36 months. Methods: This retrospective cohort study included all fetuses with a prenatal diagnosis of CSD assessed between January 2014 and December 2024 at two tertiary centers (Fetal Medicine Department of Trousseau Hospital, Paris, France, and Department of Obstetrics and Gynecology, University Hospitals Leuven, Leuven, Belgium). Lesions were reassessed and classified according to the updated Orphanet classification system for dysraphisms. Cases of open dysraphism, intermediate forms, Currarino syndrome, caudal regression syndrome and postnatally diagnosed cases were excluded. Prenatal imaging findings, pregnancy outcomes, postnatal diagnostic concordance, neurosurgical management and functional outcomes were analyzed. Results: Seventy fetuses with a prenatal diagnosis of CSD were included. Saccular forms of CSD accounted for 85.7% ( n = 60) of cases, including 33 (47.1%) cases of limited dorsal myeloschisis, 18 (25.7%) cases of posterior meningocele and nine (12.9%) cases of conus spinal cord lipoma. Most (85.7%) lesions were located at the lumbar or sacral level. Associated structural cerebral anomalies were identified prenatally in 17.1% ( n = 12) of cases. There were 59 (84.3%) live births and 11 (15.7%) terminations of pregnancy, including eight cases with major cerebral anomalies. Among liveborn infants with available data on postnatal surgical interventions ( n/N = 44/59), postnatal surgery was performed in 90.9% of cases. The prenatal diagnosis was adjusted postnatally in 4/39 (10.3%) cases with available postnatal outcome data. At 36 months, independent ambulation was achieved in 94.4% (17/18) of children with follow‐up data available at this time point. In contrast, urinary dysfunction was present in 38.9% of cases at 36 months, while gastrointestinal disorders were less frequent (22.2%). Conclusion: Using the Orphanet classification, prenatal ultrasound examination allows reliable anatomical characterization of CSD in 89.7% of cases. Motor outcomes are generally favorable, whereas urological morbidity is observed in nearly half of cases at 18 months. These are important elements to consider in prenatal counseling. © 2026 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
- Open Access
- 31 August 2026
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 326
Factors associated with maternal choice of planned mode of delivery after cesarean
- 31 August 2026
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 326
Open AccessFactors associated with maternal choice of planned mode of delivery after cesarean
- Open Access
- 24 August 2026
- Published by Elsevier in American Journal of Obstetrics & Gynecology MFM
- Vol. 8 (11)
Predictors of intraoperative conversion to cesarean hysterectomy during attempted conservative management of placenta accreta spectrum: a multicenter cohort study
- 24 August 2026
- Published by Elsevier in American Journal of Obstetrics & Gynecology MFM
- Vol. 8 (11)
Open AccessPredictors of intraoperative conversion to cesarean hysterectomy during attempted conservative management of placenta accreta spectrum: a multicenter cohort study
- Open Access
- 2 July 2026
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 175 (3) , 1549-1555
Impact of Cell Saver technology on pro‐hemostatic factors transfusion in placenta accreta spectrum interventions: A 10‐year retrospective single‐center study
Background: While Cell Saver technology effectively reduces red blood cell transfusion in the perioperative setting, its impact on the need for pro‐hemostatic factors remains unclear. The use of Cell Saver could impact the requirements of pro‐hemostatic factors. Objective: This study assesses whether the use of Cell Saver influences transfusion requirements for fresh frozen plasma, platelet concentrates, and fibrinogen in surgeries for placenta accreta spectrum (PAS) disorders. Methods: This retrospective, single‐center, before‐and‐after study was conducted in a tertiary maternity hospital. Women undergoing surgery for PAS (cesarean delivery with conservative treatment or hysterectomy) were included. Two periods were compared: before (2013–2017, Period A) and after Cell Saver implementation (2019–2023, Period B), with a 1‐year washout (2018). The primary outcome was a composite criterion: transfusion of ≥ 3 units of FFP (fresh frozen plasma) and/or ≥ 1 unit of PC (platelet concentrates) and/or ≥ 4 g fibrinogen. Univariate and multivariable logistic regression analyses were conducted, with subgroup analyses in women undergoing hysterectomy and those with blood loss ≥ 2000 mL. Results: Among 136 women (69 in Period A, 67 in Period B), Cell Saver was used in 86% of Period B cases (median volume: 769 mL). The primary outcome occurred in 42% of Period A versus 52.2% of Period B ( P = 0.23). However, multivariable analysis showed lower odds of pro‐hemostatic transfusion with Cell Saver use (adjusted odds ratio 0.21; 95% confidence interval 0.06–0.77). In patients with ≥ 2000 mL blood loss, the primary outcome was significantly less frequent in Period B (71.1% vs. 95.6%, P < 0.05). Conclusion: Cell Saver use during PAS surgery is independently associated with reduced pro‐hemostatic transfusion, especially in cases with major bleeding, supporting its routine use.
- 2 July 2026
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 175 (3) , 1549-1555
Open AccessImpact of Cell Saver technology on pro‐hemostatic factors transfusion in placenta accreta spectrum interventions: A 10‐year retrospective single‐center study
Background: While Cell Saver technology effectively reduces red blood cell transfusion in the perioperative setting, its impact on the need for pro‐hemostatic factors remains unclear. The use of Cell Saver could impact the requirements of pro‐hemostatic factors. Objective: This study assesses whether the use of Cell Saver influences transfusion requirements for fresh frozen plasma, platelet concentrates, and fibrinogen in surgeries for placenta accreta spectrum (PAS) disorders. Methods: This retrospective, single‐center, before‐and‐after study was conducted in a tertiary maternity hospital. Women undergoing surgery for PAS (cesarean delivery with conservative treatment or hysterectomy) were included. Two periods were compared: before (2013–2017, Period A) and after Cell Saver implementation (2019–2023, Period B), with a 1‐year washout (2018). The primary outcome was a composite criterion: transfusion of ≥ 3 units of FFP (fresh frozen plasma) and/or ≥ 1 unit of PC (platelet concentrates) and/or ≥ 4 g fibrinogen. Univariate and multivariable logistic regression analyses were conducted, with subgroup analyses in women undergoing hysterectomy and those with blood loss ≥ 2000 mL. Results: Among 136 women (69 in Period A, 67 in Period B), Cell Saver was used in 86% of Period B cases (median volume: 769 mL). The primary outcome occurred in 42% of Period A versus 52.2% of Period B ( P = 0.23). However, multivariable analysis showed lower odds of pro‐hemostatic transfusion with Cell Saver use (adjusted odds ratio 0.21; 95% confidence interval 0.06–0.77). In patients with ≥ 2000 mL blood loss, the primary outcome was significantly less frequent in Period B (71.1% vs. 95.6%, P < 0.05). Conclusion: Cell Saver use during PAS surgery is independently associated with reduced pro‐hemostatic transfusion, especially in cases with major bleeding, supporting its routine use.
- Open Access
- 28 June 2026
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 324, 115277
Counseling practices, opinions and personal preferences regarding mode of delivery for term breech presentation: A survey of healthcare professionals
- 28 June 2026
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 324, 115277
Open AccessCounseling practices, opinions and personal preferences regarding mode of delivery for term breech presentation: A survey of healthcare professionals
- Open Access
- 20 May 2026
- Published by Elsevier in Journal of Gynecology Obstetrics and Human Reproduction
- Vol. 55 (7) , 103217
Mode of delivery among breech presentations with and without External Cephalic Version: A retrospective observational study
- 20 May 2026
- Published by Elsevier in Journal of Gynecology Obstetrics and Human Reproduction
- Vol. 55 (7) , 103217
Open AccessMode of delivery among breech presentations with and without External Cephalic Version: A retrospective observational study
- Open Access
- 15 May 2026
- Published by Wiley in Prenatal Diagnosis
- Vol. 46 (8) , 1258-1266
Impact of Fetoscopic Surgery on the Myometrium: Experimental Study in an Ovine Model of Myelomeningocele
Objective: To investigate uterine healing at delivery after fetoscopic myelomeningocele (MMC) closure in an ovine model. Methods: This descriptive study was conducted in Romane ewes. Fetal MMC lesions were created after hysterotomy at 75 days of gestation. Fetoscopic MMC closure using three trocars was performed at 90 days of gestation and cesarean delivery at 143 days. Subtotal hysterectomy was performed, and each hysterectomy specimen was examined in fresh condition. The areas of interest and the surrounding intact tissue were then sampled en bloc and fixed in 4% buffered formaldehyde solution for 3–6 weeks. Macroscopic appearance of the scars was assessed in fresh condition. Microscopic examinations were conducted in fixed samples. Results: The uteri of six ewes were studied. Macroscopic examination revealed identifiable fetoscopic scars without any scar dehiscence. There was no evidence of a difference in thickness between scarred and healthy adjacent myometrium, although a slightly lower proportion of muscle fibers was observed in scarred areas. Conclusions: Our study demonstrates that myometrial healing of trocar orifices is complete 53 days after fetoscopic MMC closure in an ovine model. Given the limitations of an ovine model, further studies are needed to determine the risk of uterine rupture and the optimal obstetric management of patients after fetoscopic MMC closure.
- 15 May 2026
- Published by Wiley in Prenatal Diagnosis
- Vol. 46 (8) , 1258-1266
Open AccessImpact of Fetoscopic Surgery on the Myometrium: Experimental Study in an Ovine Model of Myelomeningocele
Objective: To investigate uterine healing at delivery after fetoscopic myelomeningocele (MMC) closure in an ovine model. Methods: This descriptive study was conducted in Romane ewes. Fetal MMC lesions were created after hysterotomy at 75 days of gestation. Fetoscopic MMC closure using three trocars was performed at 90 days of gestation and cesarean delivery at 143 days. Subtotal hysterectomy was performed, and each hysterectomy specimen was examined in fresh condition. The areas of interest and the surrounding intact tissue were then sampled en bloc and fixed in 4% buffered formaldehyde solution for 3–6 weeks. Macroscopic appearance of the scars was assessed in fresh condition. Microscopic examinations were conducted in fixed samples. Results: The uteri of six ewes were studied. Macroscopic examination revealed identifiable fetoscopic scars without any scar dehiscence. There was no evidence of a difference in thickness between scarred and healthy adjacent myometrium, although a slightly lower proportion of muscle fibers was observed in scarred areas. Conclusions: Our study demonstrates that myometrial healing of trocar orifices is complete 53 days after fetoscopic MMC closure in an ovine model. Given the limitations of an ovine model, further studies are needed to determine the risk of uterine rupture and the optimal obstetric management of patients after fetoscopic MMC closure.
- Open Access
- 7 March 2026
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 105 (4) , 679-686
History‐indicated cerclage versus ultrasound cervical length screening in women with a history of one extremely preterm birth: A comparative observational cohort study
Introduction: In women with a history of one extremely preterm birth, the current literature suggests that ultrasound cervical length screening offers a more favorable risk–benefit ratio than history‐indicated cerclage. However, some of the women included in previous studies were at a low risk of cervical insufficiency. Therefore, the efficacy of history‐indicated cerclage may have been underestimated. Our objective was to compare history‐indicated cerclage with ultrasound cervical length screening in women with a history of one second‐trimester loss or extremely preterm birth suggestive of cervical insufficiency. Material and Methods: We conducted a retrospective cohort study comparing two centers with different management strategies for women with a history of one second‐trimester loss or extremely preterm birth suggestive of cervical insufficiency. This study was conducted from January 1, 2015 to December 31, 2022 in two French tertiary care maternity units. In the first center, women were offered a cerclage in the first trimester (cerclage center). In the second center, women were offered an ultrasound screening with cerclage only for women with cervical shortening (ultrasound center). To target a population at high risk for cervical insufficiency, we included women with a history of one second‐trimester loss or spontaneous preterm birth before 28 weeks of gestation. We excluded women who had any of the following complications in their previous pregnancy: bleeding from placenta previa or placental abruption, intrauterine fetal death, or delivery after invasive prenatal testing. We also excluded women with a history of more than one preterm delivery. Our primary outcome was delivery before 34 weeks. A multivariable analysis was performed. Results: The rate of delivery before 34 weeks was significantly lower in the cerclage center compared with that in the ultrasound center (26/165 (15.8%) vs. 38/149 (25.5%), p = 0.032). After adjusting for confounding factors, history‐indicated cerclage was associated with a twofold decreased risk of delivery before 34 weeks compared with ultrasound cervical length screening (aOR 0.46, 95% CI 0.23–0.95). Conclusions: In women with a history of one second‐trimester loss or extremely preterm birth suggestive of cervical insufficiency, history‐indicated cerclage is associated with a lower risk of delivery before 34 weeks compared with ultrasound cervical length screening.
- 7 March 2026
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 105 (4) , 679-686
Open AccessHistory‐indicated cerclage versus ultrasound cervical length screening in women with a history of one extremely preterm birth: A comparative observational cohort study
Introduction: In women with a history of one extremely preterm birth, the current literature suggests that ultrasound cervical length screening offers a more favorable risk–benefit ratio than history‐indicated cerclage. However, some of the women included in previous studies were at a low risk of cervical insufficiency. Therefore, the efficacy of history‐indicated cerclage may have been underestimated. Our objective was to compare history‐indicated cerclage with ultrasound cervical length screening in women with a history of one second‐trimester loss or extremely preterm birth suggestive of cervical insufficiency. Material and Methods: We conducted a retrospective cohort study comparing two centers with different management strategies for women with a history of one second‐trimester loss or extremely preterm birth suggestive of cervical insufficiency. This study was conducted from January 1, 2015 to December 31, 2022 in two French tertiary care maternity units. In the first center, women were offered a cerclage in the first trimester (cerclage center). In the second center, women were offered an ultrasound screening with cerclage only for women with cervical shortening (ultrasound center). To target a population at high risk for cervical insufficiency, we included women with a history of one second‐trimester loss or spontaneous preterm birth before 28 weeks of gestation. We excluded women who had any of the following complications in their previous pregnancy: bleeding from placenta previa or placental abruption, intrauterine fetal death, or delivery after invasive prenatal testing. We also excluded women with a history of more than one preterm delivery. Our primary outcome was delivery before 34 weeks. A multivariable analysis was performed. Results: The rate of delivery before 34 weeks was significantly lower in the cerclage center compared with that in the ultrasound center (26/165 (15.8%) vs. 38/149 (25.5%), p = 0.032). After adjusting for confounding factors, history‐indicated cerclage was associated with a twofold decreased risk of delivery before 34 weeks compared with ultrasound cervical length screening (aOR 0.46, 95% CI 0.23–0.95). Conclusions: In women with a history of one second‐trimester loss or extremely preterm birth suggestive of cervical insufficiency, history‐indicated cerclage is associated with a lower risk of delivery before 34 weeks compared with ultrasound cervical length screening.
- Open Access
- 7 February 2026
- Published by Elsevier in Gynécologie Obstétrique Fertilité & Sénologie
- Vol. 54 (7-8) , 404-407
Comment je fais… une « Césarienne participative » ?
- 7 February 2026
- Published by Elsevier in Gynécologie Obstétrique Fertilité & Sénologie
- Vol. 54 (7-8) , 404-407
Open AccessComment je fais… une « Césarienne participative » ?
- 15 January 2026
- Published by Elsevier in Gynécologie Obstétrique Fertilité & Sénologie
- Vol. 54 (3) , 113-131
Accouchement des grossesses gémellaires : recommandations pour la pratique clinique du Collège national des gynécologues et obstétriciens français
- 15 January 2026
- Published by Elsevier in Gynécologie Obstétrique Fertilité & Sénologie
- Vol. 54 (3) , 113-131
Accouchement des grossesses gémellaires : recommandations pour la pratique clinique du Collège national des gynécologues et obstétriciens français